Published in Ophthalmology on March 01, 2010
Pseudoxanthoma elasticum and skin: Clinical manifestations, histopathology, pathomechanism, perspectives of treatment. Intractable Rare Dis Res (2015) 0.98
An update on the ocular phenotype in patients with pseudoxanthoma elasticum. Front Genet (2013) 0.94
The relative impact of vision impairment and cardiovascular disease on quality of life: the example of pseudoxanthoma elasticum. Health Qual Life Outcomes (2011) 0.83
Age-related macular degeneration. Lancet (2012) 4.17
Seven new loci associated with age-related macular degeneration. Nat Genet (2013) 3.81
Fundus autofluorescence imaging: review and perspectives. Retina (2008) 3.22
Ranibizumab for predominantly classic neovascular age-related macular degeneration: subgroup analysis of first-year ANCHOR results. Am J Ophthalmol (2007) 3.00
Progression of geographic atrophy and impact of fundus autofluorescence patterns in age-related macular degeneration. Am J Ophthalmol (2006) 2.80
Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. Am J Clin Nutr (2009) 2.71
Complement factor H binds malondialdehyde epitopes and protects from oxidative stress. Nature (2011) 2.64
Intraocular pharmacokinetics of bevacizumab after a single intravitreal injection in humans. Am J Ophthalmol (2008) 2.52
A novel gene for Usher syndrome type 2: mutations in the long isoform of whirlin are associated with retinitis pigmentosa and sensorineural hearing loss. Hum Genet (2006) 2.27
Systemic complement activation in age-related macular degeneration. PLoS One (2008) 2.18
The "diffuse-trickling" fundus autofluorescence phenotype in geographic atrophy. Invest Ophthalmol Vis Sci (2014) 2.06
Findings in fluorescein angiography and optical coherence tomography after intravitreal bevacizumab in type 2 idiopathic macular telangiectasia. Ophthalmology (2007) 2.03
High-resolution spectral domain-OCT imaging in geographic atrophy associated with age-related macular degeneration. Invest Ophthalmol Vis Sci (2008) 2.03
An update on the genetics of age-related macular degeneration. Mol Vis (2007) 1.95
Pseudoxanthoma elasticum: genetics, clinical manifestations and therapeutic approaches. Surv Ophthalmol (2009) 1.92
Long-term benefit of sustained-delivery fluocinolone acetonide vitreous inserts for diabetic macular edema. Ophthalmology (2011) 1.79
Classification of fundus autofluorescence patterns in early age-related macular disease. Invest Ophthalmol Vis Sci (2005) 1.76
Effects of n-3 fatty acids on macro- and microvascular function in subjects with type 2 diabetes mellitus. Am J Clin Nutr (2010) 1.75
Effects of low- and high-advanced glycation endproduct meals on macro- and microvascular endothelial function and oxidative stress in patients with type 2 diabetes mellitus. Am J Clin Nutr (2007) 1.56
Prophylactic laser treatment hastens choroidal neovascularization in unilateral age-related maculopathy: final results of the drusen laser study. Am J Ophthalmol (2006) 1.50
Fundus autofluorescence and progression of age-related macular degeneration. Surv Ophthalmol (2009) 1.46
Clinical evaluation of simultaneous confocal scanning laser ophthalmoscopy imaging combined with high-resolution, spectral-domain optical coherence tomography. Acta Ophthalmol (2010) 1.44
Macular telangiectasia type 2. Prog Retin Eye Res (2012) 1.44
Increasing the yield in targeted next-generation sequencing by implicating CNV analysis, non-coding exons and the overall variant load: the example of retinal dystrophies. PLoS One (2013) 1.40
Truncating mutation of the DFNB59 gene causes cochlear hearing impairment and central vestibular dysfunction. Hum Mutat (2007) 1.38
Combined confocal scanning laser ophthalmoscopy and spectral-domain optical coherence tomography imaging of reticular drusen associated with age-related macular degeneration. Ophthalmology (2010) 1.38
Circulating calcitriol concentrations and total mortality. Clin Chem (2009) 1.38
Treatment patterns, visual acuity and quality-of-life outcomes of the WAVE study - a noninterventional study of ranibizumab treatment for neovascular age-related macular degeneration in Germany. Acta Ophthalmol (2012) 1.38
Eye health in East Timor. Ophthalmology (2007) 1.37
Intraocular pharmacokinetics after a single intravitreal injection of 1.5 mg versus 3.0 mg of bevacizumab in humans. Retina (2011) 1.37
Incidence of blindness and severe visual impairment in Germany: projections for 2030. Invest Ophthalmol Vis Sci (2011) 1.36
Prevalence and causes of registered blindness in the largest federal state of Germany. Br J Ophthalmol (2011) 1.36
Reticular drusen associated with geographic atrophy in age-related macular degeneration. Invest Ophthalmol Vis Sci (2011) 1.34
The role of the complement system in age-related macular degeneration. Dtsch Arztebl Int (2014) 1.34
CFH, C3 and ARMS2 are significant risk loci for susceptibility but not for disease progression of geographic atrophy due to AMD. PLoS One (2009) 1.34
Correlation between the area of increased autofluorescence surrounding geographic atrophy and disease progression in patients with AMD. Invest Ophthalmol Vis Sci (2006) 1.34
SPP1 promoter polymorphisms: identification of the first modifier gene for pseudoxanthoma elasticum. Clin Chem (2007) 1.33
Two-year safety and efficacy of ranibizumab 0.5 mg in diabetic macular edema: interim analysis of the RESTORE extension study. Ophthalmology (2013) 1.33
Intraocular pharmacokinetics of ranibizumab following a single intravitreal injection in humans. Am J Ophthalmol (2012) 1.32
Benfotiamine prevents macro- and microvascular endothelial dysfunction and oxidative stress following a meal rich in advanced glycation end products in individuals with type 2 diabetes. Diabetes Care (2006) 1.31
Fundus autofluorescence and fundus perimetry in the junctional zone of geographic atrophy in patients with age-related macular degeneration. Invest Ophthalmol Vis Sci (2004) 1.31
Combined treatment of acute subretinal haemorrhages with intravitreal recombined tissue plasminogen activator, expansile gas and bevacizumab: a retrospective pilot study. Acta Ophthalmol (2008) 1.28
Blindness and visual impairment in Germany: a slight fall in prevalence. Dtsch Arztebl Int (2012) 1.27
Microperimetric assessment of patients with type 2 idiopathic macular telangiectasia. Invest Ophthalmol Vis Sci (2007) 1.26
Age-related structural abnormalities in the human retina-choroid complex revealed by two-photon excited autofluorescence imaging. J Biomed Opt (2007) 1.26
Proteins modified by malondialdehyde, 4-hydroxynonenal, or advanced glycation end products in lipofuscin of human retinal pigment epithelium. Invest Ophthalmol Vis Sci (2003) 1.26
Treatment of choroidal neovascularization due to angioid streaks: a comprehensive review. Retina (2013) 1.24
Evaluation of autofluorescence imaging with the scanning laser ophthalmoscope and the fundus camera in age-related geographic atrophy. Am J Ophthalmol (2008) 1.23
Reading performance is reduced by parafoveal scotomas in patients with macular telangiectasia type 2. Invest Ophthalmol Vis Sci (2008) 1.23
In vivo visualization of dendritic cells, macrophages, and microglial cells responding to laser-induced damage in the fundus of the eye. Invest Ophthalmol Vis Sci (2008) 1.22
Long-term effectiveness of intravitreal bevacizumab for choroidal neovascularization secondary to angioid streaks in pseudoxanthoma elasticum. Retina (2011) 1.22
Monthly ranibizumab for choroidal neovascularizations secondary to angioid streaks in pseudoxanthoma elasticum: a one-year prospective study. Am J Ophthalmol (2011) 1.22
Effects of lipid peroxidation products on lipofuscinogenesis and autophagy in human retinal pigment epithelial cells. Exp Eye Res (2010) 1.22
Two-photon-excited fluorescence imaging of human RPE cells with a femtosecond Ti:Sapphire laser. Invest Ophthalmol Vis Sci (2006) 1.19
Concordance of disease progression in bilateral geographic atrophy due to AMD. Invest Ophthalmol Vis Sci (2009) 1.17
Changes in fundus autofluorescence in patients with age-related maculopathy. Correlation to visual function: a prospective study. Graefes Arch Clin Exp Ophthalmol (2004) 1.17
Confocal blue reflectance imaging in type 2 idiopathic macular telangiectasia. Invest Ophthalmol Vis Sci (2008) 1.16
Abnormal macular pigment distribution in type 2 idiopathic macular telangiectasia. Retina (2008) 1.15
Role of serum fetuin-A, a major inhibitor of systemic calcification, in pseudoxanthoma elasticum. Clin Chem (2005) 1.15
Multimodal imaging including spectral domain OCT and confocal near infrared reflectance for characterization of outer retinal pathology in pseudoxanthoma elasticum. Invest Ophthalmol Vis Sci (2009) 1.14
Pseudoxanthoma elasticum: genetic variations in antioxidant genes are risk factors for early disease onset. Clin Chem (2007) 1.14
Keypathophysiologic pathways in age-related macular disease. Graefes Arch Clin Exp Ophthalmol (2004) 1.13
The significance of the complement system for the pathogenesis of age-related macular degeneration - current evidence and translation into clinical application. Graefes Arch Clin Exp Ophthalmol (2010) 1.12
Structure-function correlation of the human central retina. PLoS One (2010) 1.12
Familial asymptomatic macular telangiectasia type 2. Ophthalmology (2009) 1.12
Quantification of reduced macular pigment optical density in the central retina in macular telangiectasia type 2. Exp Eye Res (2009) 1.10
A subgroup of age-related macular degeneration is associated with mono-allelic sequence variants in the ABCA4 gene. Invest Ophthalmol Vis Sci (2012) 1.10
Effects of lipid peroxidation-related protein modifications on RPE lysosomal functions and POS phagocytosis. Invest Ophthalmol Vis Sci (2007) 1.10
Analysis of digital scanning laser ophthalmoscopy fundus autofluorescence images of geographic atrophy in advanced age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol (2002) 1.09
The impact of diabetic retinopathy and diabetic macular edema on health-related quality of life in type 1 and type 2 diabetes. Invest Ophthalmol Vis Sci (2012) 1.08
Poor outcome in end-stage heart failure patients with low circulating calcitriol levels. Eur J Heart Fail (2008) 1.06
Tracking progression with spectral-domain optical coherence tomography in geographic atrophy caused by age-related macular degeneration. Invest Ophthalmol Vis Sci (2010) 1.06
Rapid vessel regression, protease inhibition, and stromal normalization upon short-term vascular endothelial growth factor receptor 2 inhibition in skin carcinoma heterotransplants. Am J Pathol (2005) 1.05